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http://dx.doi.org/10.1016/j.stemcr.2016.06.008SUMMARYTight regulation of the balance between self-renewal and differentiation of neural stem cells is crucial to assure proper neural develop-
ment. In this context, Notch signaling is a well-known promoter of stemness. In contrast, the bifunctional brain-enriched microRNA
miR-9/9* has been implicated in promoting neuronal differentiation. Therefore, we set out to explore the role of both regulators in
human neural stem cells. We found that miR-9/9* decreases Notch activity by targeting NOTCH2 and HES1, resulting in an enhanced
differentiation. Vice versa, expression levels of miR-9/9* depend on the activation status of Notch signaling. While Notch inhibits
differentiation of neural stem cells, it also induces miR-9/9* via recruitment of the Notch intracellular domain (NICD)/RBPj transcrip-
tional complex to the miR-9/9*_2 genomic locus. Thus, our data reveal a mutual interaction between bifunctional miR-9/9* and the
Notch signaling cascade, calibrating the delicate balance between self-renewal and differentiation of human neural stem cells.INTRODUCTION
Embryonic and induced pluripotent stem cell-derived neu-
ral stem cells represent promising in vitro model systems to
explore early stages of human neural development. Our
group has recently established homogeneous populations
of long-term self-renewing neuroepithelial-like stem (lt-
NES) cells from both human embryonic stem cells (ESCs)
and induced pluripotent stem (iPS) cells. Lt-NES cells can
be continuously propagated in the presence of fibroblast
growth factor 2 (FGF2) and epidermal growth factor (EGF).
Upon growth factor withdrawal, they show stable and
robust neurogenesis and gliogenesis independent of their
passage number (Falk et al., 2012; Koch et al., 2009).Wepre-
viously demonstrated that lt-NES cells depend on Notch
signaling for their maintenance, and that blocking Notch
activity delays their G1/S-phase transition and commits
them to neuronal differentiation (Borghese et al., 2010).
Notch is a transmembrane receptor whose signaling is
initiated by binding to ligands (Delta or Jagged) on an adja-
cent cell. In humans, four isoforms of the Notch receptor
exist, namely NOTCH1–4 (Lasky and Wu, 2005). Upon
ligand binding, the Notch intracellular domain (NICD) is
released by proteolytic cleavage steps carried out sequen-
tially by an ADAM protease and the g-secretase complex.
NICD translocates into the nucleus where it associates
with the DNA binding recombination signal binding pro-
tein for immunoglobulin kappa J region (RBPj) and recruits
co-activator of transcription Mastermind-like (MAML) toStem Cell
This is an open access article under the Cassemble a transcriptional complex that activates gene
expression (reviewed in Louvi and Artavanis-Tsakonas,
2006). This leads to transcription of downstream targets
such as HES and HES-related (HESR or HEY) basic helix-
loop-helix transcription factors as well as cell-cycle regula-
tors (reviewed in Andersson et al., 2011). Notch signaling is
known to impact on neural progenitor maintenance and
cell fate (reviewed in Pierfelice et al., 2011).
More recently, microRNAs (miRNAs) have emerged as
critical regulators of neural progenitor development and
cell fate (Coolen and Bally-Cuif, 2009; Hebert and De
Strooper, 2009; Schratt, 2009). miRNAs are endogenously
expressed RNA molecules 22–25 nucleotides in length
that are transcribed from intragenic and intergenic regions
in the genome. The primary transcript (pri-miRNA) is usu-
ally processed into a hairpin-shaped precursor (pre-miRNA)
by Drosha/DGCR8 and exported to the cytosol, where it is
further converted into the mature miRNA by Dicer and
incorporated into the RISC complex (reviewed in Bartel,
2004; Winter et al., 2009). Within the miRISC, miRNAs
may regulate the expression of hundreds of mRNA targets
at a posttranscriptional level by binding to their 30 UTRs
and triggering either transcript degradation or translational
inhibition (reviewed in Bartel, 2009).
miRNAs often take part in fine-tuning major signaling
pathways (Inui et al., 2010). The interaction betweenNotch
signaling and anmiRNA, namelymiR-9a, was first described
inDrosophila in thecontextof sensoryorganprecursordevel-
opment (Li et al., 2006). More recently, the existence of anReports j Vol. 7 j 207–219 j August 9, 2016 j ª 2016 The Author(s). 207
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interaction between Notch signaling and miR-9 has been
proposed also in the context of vertebrate neural develop-
ment by studies in zebrafish, frog, and mouse (Bonev et al.,
2011, 2012; Coolen et al., 2012). MiR-9 is evolutionarily
conserved from insects to humans (Yuva-Aydemir et al.,
2011). Data from mouse revealed that it is specifically ex-
pressed in the brain (Lagos-Quintana et al., 2002). The
pri-forms of miR-9 are bifunctional, as all three primary
transcripts coding for miR-9 also encode a second miRNA
referred to as miR-9*, which shows a lower expression rate
(Yuva-Aydemir et al., 2011). MiR-9 has been intensively
studied and shown to play important developmental roles
in neural stem cell proliferation, migration, and differentia-
tion, depending on the spatial and temporal context (re-
viewed in Gao, 2010; Stappert et al., 2014). Although less
intensively studied, its sister strand miR-9* has also been
implicated in neural development (Packer et al., 2008) and
in modulating dendritic growth (Yoo et al., 2009) as well as
stemness of glioma cells (Jeon et al., 2011). Recently, we
found that bifunctional miR-9/9* contributes to the switch
of lt-NES cells from self-renewal to neuronal differentiation
(Roese-Koerner et al., 2013).
Here, we show that Notch and miR-9/9* have opposing
effects on human neural stem cell proliferation and differ-
entiation but also directly regulate each other.While Notch
contributes to the transcription of miR-9/9*, mature miR-9
and miR-9* negatively regulate the Notch pathway by
targeting NOTCH2 and HES1, thus providing a reciprocally
regulated system for calibrating human neural stem cell
proliferation and differentiation.RESULTS
miR-9 and miR-9* Target Multiple Components of the
Notch Pathway
In previous work, we screened for the expression profile of
330 human miRNAs in human ESCs (hESCs) from the I3
line, lt-NES cells derived from those hESCs, and their differ-
entiated neuronal progeny after 15 and 30 days of growth
factor withdrawal (Stappert et al., 2013). We found that
miR-9 and miR-9* are expressed in lt-NES cells and that
their levels increase during neuronal differentiation. We
also showed that bifunctional miR-9/9* contributes to the
transition of these lt-NES cells from self-renewal to
neuronal differentiation (Roese-Koerner et al., 2013).
Target prediction analyses show that target sites for miR-9
andmiR-9* can be found in the 30 UTRs of several members
of the Notch signaling pathway (Table S1).
We particularly focused our attention on NOTCH1,
NOTCH2, and HES1. Mouse Hes1 and its homologs in
frog (Hairy1) and zebrafish (Her6) were all found to be
targets of miR-9 (Bonev et al., 2011, 2012; Coolen et al.,208 Stem Cell Reports j Vol. 7 j 207–219 j August 9, 20162012). Data generated in mouse mesenchymal stem cells
and human breast cancer cells showed that NOTCH1 is
regulated bymiR-9 (Jing et al., 2011;Mohammadi-Yeganeh
et al., 2015). In contrast to Hes1 and Notch1, there were no
previous data indicating Notch2 as a target of miR-9/9*.We
chose NOTCH2 as an interesting novel candidate for
different reasons. First, NOTCH2 has the longest 30 UTR
of all Notch receptors (NOTCH1, 1,627 nt; NOTCH2,
3,751 nt; NOTCH3, 1,028 nt; NOTCH4, 593 nt), which
could suggest anmiRNA-based regulation of its expression.
Second, targeting of the NOTCH2 30 UTR by miR-9
and miR-9* was predicted by several algorithms (Table S1).
Third, previous reports point to opposing roles of miR-9/9*
and Notch2 in neurogenesis. While overexpression of
miR-9/9* was shown to promote neuronal fate and reduce
the number of glial fibrillary acidic protein-positive cells
during neural differentiation of mouse ESCs (Krichevsky
et al., 2006), Notch2-ICD (N2ICD) expression was shown
to support expansion of the neurogenic niche in vivo
(Tchorz et al., 2012) and to induce the differentiation of
astrocytes at the expense of neurons and oligodendrocytes
in cultured neural stem cells (Tchorz et al., 2012).
To explore whether human NOTCH1, NOTCH2, and
HES1 could be targets of miR-9 and miR-9*, we overex-
pressed the genomic sequence of the miR-9_1 locus in lt-
NES cells derived from I3 hESCs in a doxycycline-inducible
manner and assessed changes in the expression levels of
NOTCH1, NOTCH2, and HES1 by western blotting and
real-time qRT-PCR analyses. After 4 days of doxycycline
treatment, we found a robust increase in the expression
of mature miR-9 and miR-9* in I3 lt-NES cells cultured in
the presence of FGF2 and EGF (Figure 1A). Under these
conditions, bIII-tubulin protein levels were slightly
increased in miR-9/9*-overexpressing cultures (Figures 1B
and 1C), which is in line with our earlier observation of
an enhanced rate of spontaneous neuronal differentiation
uponmiR-9/9* overexpression (Roese-Koerner et al., 2013).
However, Nestin protein levels were unchanged (Figures 1B
and 1C), indicating that Nestin is less responsive to
miR-9/9* overexpression. Levels of NOTCH1 did not
significantly change (Figures 1D–1F), while we observed a
significant decrease inNOTCH2mRNA levels andNOTCH2
protein variants, i.e., full-length NOTCH2 and N2ICD
(Figures 1H–1J). Likewise, both transcript and protein
levels ofHES1were reduced uponmiR-9/9* overexpression
(Figures 1L–1N).
To assess whether the regulation of Notch genes by
miR-9/9* is a peculiarity of lt-NES cells rather than a
more general phenomenon, we analyzed the impact of
miR-9/9* overexpression in another neural stem cell
system (Figure S1). We chose the recently described
small-molecule neural precursor cells (smNPC; Reinhardt
et al., 2013), which are considered to represent an early
Figure 1. miR-9/9* Target NOTCH2 and HES1
(A) qRT-PCR analyses of miR-9, miR-9*, and miR-125b in lt-NES cells overexpressing the miR-9-1 genomic sequence (9/9*) or GFP (used as
control) after 4 days of doxycycline treatment. Data are normalized to miR-16 reference levels and presented as average changes + SEM
relative to expression in GFP-expressing lt-NES cells (GFP, equal to 1; nR 3; **p% 0.01, Student’s t test).
(B, D, H, L) Representative western blot analyses of bIII-tubulin and Nestin (B), full-length NOTCH1 (D), NOTCH2 (H), and their respective
intracellular domains (ICD), as well as HES1 (L) protein levels in I3 lt-NES cells overexpressing the miR-9/9* locus induced by 4 days of
doxycycline treatment compared with a GFP control construct (nR 3). b-Actin is shown as loading control.
(C, E, I, M) Corresponding densitometric analyses of bIII-tubulin and Nestin (C), NOTCH1 and N1ICD (E), NOTCH2 and N2ICD (I), and HES1
(M) protein levels normalized to b-actin. Data are presented as mean ± SEM relative to expression in I3 lt-NES cells overexpressing GFP
(equal to 1; nR 3; *p% 0.05, **p% 0.01, Student’s t test).
(F, J, N) qRT-PCR analyses of NOTCH1 (F), NOTCH2 (J), and HES1 (N) transcript levels in the conditions described above. Data are normalized
to 18S rRNA reference levels and presented as average changes + SEM relative to expression in lt-NES cells overexpressing GFP (equal to 1;
n = 6; *p% 0.05, **p% 0.01, Student’s t test).
(G, K, O) Analyses of luciferase activity in I3 lt-NES cells expressing the 30 UTRs of NOTCH1 (G), NOTCH2 (K), and HES1 (O) cloned
downstream of Renilla (Ren) luciferase and transfected with synthetic mimics for miR-9 and miR-9* (9/9*) or a short RNA scrambled
control (ctrl). Data are normalized to firefly (Fire) luciferase activity and presented as average changes + SEM relative to activity in I3
lt-NES cells transfected with the scrambled control (ctrl, equal to 1; n = 5; *p% 0.05, Student’s t test). All experiments were performed in
I3 lt-NES cells cultured under self-renewing conditions, i.e., in the presence of EGF and FGF2.pre-rosette neural plate border fate compared with the
lt-NES cells that grow as small neural rosettes reminiscent
of the early neural tube (Koch et al., 2009). smNPCs
transduced with miR-9/9* lentivirus (Figure S1A) alreadyshowed a downregulation of NOTCH2 and HES1 mRNA
after 48 hr of doxycycline-induced overexpression, con-
firming the data gathered in lt-NES cells (Figure S1B). At
this time point the amount of bIII-tubulin-positive cellsStem Cell Reports j Vol. 7 j 207–219 j August 9, 2016 209
was not affected, indicating that the effect on NOTCH2
and HES1 after short-term overexpression of miR-9/9* is
due to a direct effect rather than a change in cell fate
(Figure S1C). However, overexpression of miR-9/9* over
4 days induced a slight increase in neuronal differentia-
tion of smNPCs (Figure S1C), similar to what we had
earlier observed in lt-NES cells (Roese-Koerner et al.,
2013).
To follow up on these observations, we generated re-
porter constructs carrying a Renilla luciferase fused to the
30 UTRs ofNOTCH1,NOTCH2, orHES1 and an unregulated
firefly luciferase as expression control. These constructs
were transfected separately into I3 lt-NES cell lines express-
ing either the genomic sequence of the miR-9_1 locus or a
scrambled control. Upon overexpression of miR-9/9*, we
found a significant decrease in Renilla luciferase activity
in lt-NES cells for the constructs harboring NOTCH2 and
HES1 30 UTRs (Figures 1K and 1O). In contrast, no signifi-
cant change in luciferase activity was observed when
testing the NOTCH1 30 UTR (Figure 1G). Together, these
data strongly suggest that NOTCH2 and HES1, but not
NOTCH1, are direct targets of miR-9/9* activity in human
neural stem cells.
Modulation of the Balance between miR-9/9* and
Notch Activity Results in an Altered Differentiation
Potential of lt-NES Cells
We previously showed that Notch signaling is crucial
for maintaining lt-NES cells in a self-renewing undiffer-
entiated state, while its inhibition leads to a delay in
G1/S-phase transition and premature onset of neuronal
differentiation (Borghese et al., 2010). To understand the
biological relevance of a potential targeting of Notch
pathway components by miR-9/9*, we performed loss-
and gain-of-function studies in differentiating lt-NES cells.
Differentiation was induced by growth factor withdrawal
for 7 days. When we inhibited miR-9/9* activity by consec-
utive transfection of synthetic inhibitors, the number of
bIII-tubulin-positive cells was reduced by 50% compared
with vehicle control cultures treated with DMSO alone
and transfected with a short scrambled control RNA
(Figures 2A and 2B). In contrast, inhibition of Notch activ-
ity via N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenyl-
glycine (DAPT; administered every day during the 7 days
differentiation paradigm) led to a 3-fold increase in the
number of bIII-tubulin-positive cells compared with con-
trol cultures (Figures 2A and 2B). Interestingly, when
combining these two conditions we observed that the
impairment of neuronal differentiation induced by inhibi-
tion of miR-9/9* activity was abolished by DAPT-mediated
inhibition of Notch activity (Figures 2A and 2B). Similar
results could be obtained in lt-NES cells derived from
another parental hESC line (H9.2; Figure S2).210 Stem Cell Reports j Vol. 7 j 207–219 j August 9, 2016When lt-NES cells were co-transfected with synthetic
mimics for miR-9 and miR-9* the number of bIII-tubulin-
positive cells increased by 2-fold compared with control
cultures (Figures 2C and 2D). In contrast, overexpression
of constitutively active N2ICD (Capobianco et al., 1997)
led to a5-fold decrease in the number of bIII-tubulin-pos-
itive cells compared with control cultures (Figures 2C and
2D). When combining the two conditions, we observed
that forced activation ofNotch signaling by overexpression
of N2ICD, which lacks the NOTCH2 30 UTR with the bind-
ing sites for miR-9 and miR-9*, abolished the promotion of
neuronal differentiation induced by ectopic miR-9/9*
activity.
Taken together with the miR-9-based repression of
NOTCH2 and HES1 shown above, these data strongly
indicate that in lt-NES cells the Notch pathway is a func-
tional target of miR-9/9* activity and that miR-9/9*-based
promotion of neuronal differentiation is, at least in part,
mediated via the Notch pathway.
miR-9 Expression is Decreased upon g-Secretase
Inhibition
Previous studies have shown that mice lacking Presinilin1
(Psen1), which is the catalytic component of the g-secre-
tase complex, exhibit decreased miR-9 expression (Kri-
chevsky et al., 2003). In line with this, more recent data
in zebrafish also showed decreased miR-9 expression in
response to pharmacological inhibition of the g-secretase
complex (Coolen et al., 2012). As miR-9 is expressed in
lt-NES cells, we asked whether treating these cells with
DAPT, a g-secretase inhibitor, could lead to similar results.
To avoid any differentiation bias in this experiment, we
added DAPT to the normal lt-NES cell maintenance me-
dium (containing FGF2 and EGF) for 12 to 48 hr only.
This short-term application of DAPT resulted in a robust
2-fold downregulation of miR-9 expression in I3 lt-NES
cells and also reduced the expression of the known Notch
downstream target HEY1 (Figures 3A and 3B). In contrast,
expression of mature miR-125b, another brain-enriched
miRNA shown to be expressed in lt-NES cells (Roese-
Koerner et al., 2013), was not affected by DAPT treatment
(Figure 3C). The decrease of mature miR-9 but not miR-
125b was validated by northern blot analyses in the
same conditions (Figure 3D). This result confirms the spec-
ificity of the impact of g-secretase inhibition on miR-9
expression. Similar data were obtained in proliferating
H9.2 lt-NES cells and smNPCs (Figures S3A–S3C), indi-
cating that the impact of DAPT on miR-9 expression is
independent of the cell line used.
To further prove that miR-9 expression in lt-NES cells
is affected by g-secretase inhibition, we monitored the
impact of DAPT on the activity of a luciferase reporter
carrying miR-9 binding sites downstream of the Renilla
Figure 2. The Impact of miR-9/9* on lt-NES Cell Differentiation Is Mediated by Targeting of the Notch Signaling Pathway
(A) Representative immunostainings for bIII-tubulin in I3 lt-NES cells transfected with synthetic inhibitors for miR-9 and miR-9*
(Inh-9/9*) or a short scrambled control RNA (ctrl) and treated with DAPT or DMSO (vehicle control), after 7 days of in vitro differ-
entiation.
(B) Corresponding quantifications of the relative number of bIII-tubulin-positive cells in lt-NES cultures after 7 days of in vitro differ-
entiation in the conditions described above.
(C) Representative immunostainings for bIII-tubulin in I3 lt-NES cells transduced with lentiviral vectors overexpressing N2ICD or GFP
control and transfected with synthetic mimics for miR-9 and miR-9* (9/9*) or a short scrambled control RNA (ctrl), after 7 days of in vitro
differentiation.
(D) Corresponding quantifications as described in (B). DAPI stains nuclei.
Scale bars indicate 100 mm. All data are presented as mean + SEM (n = 3; *p% 0.05, **p% 0.01; ***p% 0.001, Student’s t test).luciferase cDNA. To validate the sensitivity of the re-
porter system in lt-NES cells, we modulated endogenous
levels of miR-9 by transfection of a synthetic mimic or
inhibitor of miR-9. Transfection of I3 lt-NES cells with
an miR-9 mimic resulted in a relative decrease of
Renilla luciferase activity to 47% ± 7% compared with
the baseline luciferase activity (set to 100%) of reporter
cells treated with DMSO as vehicle control and trans-
fected with a short scrambled control RNA (Figure 3E).
In contrast, treatment with a miR-9 inhibitor increased
the Renilla luciferase activity to 119% ± 17% (Figure 3E).
Similar to miR-9 inhibition, treatment with DAPT
induced a slight, yet significant increase (118% ± 6%; Fig-
ure 3E) in luciferase activity. From these data we conclude
that, as previously shown for mouse (Krichevsky et al.,2003) and zebrafish (Coolen et al., 2012), expression
of miR-9 is also affected by g-secretase activity in human
neural stem cells.
Expression of miR-9 and miR-9* is Affected by
Modulation of Notch Activity
While Notch is a well-known substrate of g-secretase and
DAPT is able to inhibit Notch activity in lt-NES cells
((Borghese et al., 2010); Figure 3B), DAPT-based inhibition
of g-secretase may also impact on other substrates. To
confirm that the observed impact of DAPT on miR-9
expression results frommodulation of the Notch pathway,
we went on to assess expression of mature miR-9 and
miR-9* in conditions of specific Notch loss and gain of
function. For specific interference with Notch activity inStem Cell Reports j Vol. 7 j 207–219 j August 9, 2016 211
Figure 3. Impact of Pharmacological Notch Inhibition on miR-9 Expression in Proliferating lt-NES Cells
(A–C) qRT-PCR analyses monitoring mature miR-9 (A), HEY1 (B), and miR-125b (C) in I3 lt-NES cells treated with DAPT (+) or DMSO
(, vehicle control) for 12, 24, and 48 hr in the presence of EGF and FGF2. Data are normalized to miR-16 (A, C) or 18S rRNA (B) reference
levels and presented as average changes + SEM relative to expression in I3 lt-NES cells treated with DMSO for 12 hr (equal to 1; n = 4 [A, C];
n = 6 [B]; *p% 0.05, **p% 0.01, Student’s t test).
(D) Northern blot analyses showing the expression of miR-9 or miR-125b in the samples described above. U6 small nuclear RNA was used as
loading control.
(E) Analyses of Renilla luciferase activity in I3 lt-NES cells treated with DAPT or transfected with a synthetic mimic or inhibitor of miR-9.
Data are normalized to firefly luciferase activity and presented as average changes + SEM relative to activity in DMSO-treated I3 lt-NES cells
transfected with a short scrambled control RNA (ctrl, equal to 1; n = 4; *p% 0.05, Student’s t test).lt-NES cells we conditionally overexpressed a truncated
form of the NICD co-activator of transcription MAML1
that was previously shown to act in a dominant-negative
manner (Weng et al., 2003); hence, we refer to it as DN-
MAML1. To achieve Notch gain of function we condition-
ally overexpressed the human NOTCH1-ICD (N1ICD)
construct (Capobianco et al., 1997) in I3 lt-NES cells under
proliferating conditions. Efficiency of conditional Notch
gain and loss of function was assessed by monitoring
mRNA levels of the known Notch transcriptional target
HEY1 (Figure 4A). Like HEY1 mRNA, expression of both
miR-9 and miR-9* was strongly increased upon NICD over-
expression and significantly decreased upon DN-MAML1
overexpression (Figures 4B and 4C). In contrast, expression
of miR-125b did not change upon modulation of Notch
activity (Figures 4D and S4A). Elevated levels of miR-9
and miR-9* were also observed after transduction of I3
lt-NES cells with a human NOTCH2-ICD (N2ICD)
construct (Figure 4D). Taken together with the finding212 Stem Cell Reports j Vol. 7 j 207–219 j August 9, 2016that miR-9/9* targets NOTCH2 (Figures 1H–1K), these
data indicate that miR-9 and NOTCH2 mutually regulate
each other.
Since transcriptional regulation is not the only mecha-
nism impacting on the levels of mature miRNAs, we as-
sessed the expression of the primary transcript produced
by the miR-9_2 locus (pri-miR-9_2) in I3 lt-NES cells under
conditional gain and loss of Notch activity. Using PCR
analysis, we were able to show that in I3 lt-NES cells as
well as in smNPCs only the miR-9_2 locus is expressed
in a detectable manner (Figures 4E and S3D). As shown
in Figure 4F, pri-miR-9_2 levels were significantly
decreased upon DN-MAML1 overexpression, and dramat-
ically increased upon NICD overexpression. Similarly,
DAPT treatment of smNPCs also resulted in a drastic
decrease of pri-miR-9_2 expression (Figure S3E). These
data suggest that Notch signaling regulates miR-9 and
miR-9* expression at the transcriptional level in both
lt-NES cells and smNPCs.
Figure 4. miR-9/9* Expression in Proliferating lt-NES Cells upon Modulation of Notch Pathway Activity
(A–C) qRT-PCR analyses of HEY1mRNA (A), miR-9 (B), and miR-9* (C) in I3 lt-NES cells transduced with lentiviral vectors overexpressing in
a doxycycline-dependent manner GFP, NICD, or DN-MAML1 after 4 days of doxycycline treatment in the presence or absence of DAPT. Data
are normalized to 18S rRNA (A) and miR-16 (B, C) reference levels and presented as average changes + SEM relative to expression in
GFP-expressing I3 lt-NES cells (GFP, equal to 1; nR 4; *p% 0.05, **p% 0.01, Student’s t test).
(D) qRT-PCR analyses of miR-9, miR-9*, and miR-125b in I3 lt-NES cells transduced with lentiviral vectors overexpressing in a doxycycline-
dependent manner GFP, N2ICD, or DN-MAML1 after 4 days of doxycycline treatment. Data are normalized to RNU5A reference levels and
presented as average changes + SEM relative to expression in GFP-expressing lt-NES cells (GFP, equal to 1; n = 3; *p% 0.05, **p% 0.01,
Student’s t test).
(E) Representative images of PCR analyses for expression of the three pri-miR-9 forms (pri-9_1, pri-9_2, and pri-9_3) in I3 lt-NES cells
(NES) and fetal brain RNA (FB). 18S rRNA levels were used as loading control.
(F) qRT-PCR analyses of pri-miR-9_2 transcript levels (pri-9_2) in the samples described above. Data are normalized to 18S rRNA reference
levels and are presented as average changes + SEM relative to expression in GFP-expressing I3 lt-NES cells (GFP, equal to 1; n R 4;
*p% 0.05, **p% 0.01, Student’s t test).
(G) Representative images of PCR analyses of the predicted RBPj binding sites in the genomic regions 10 kb upstream of pre-miR-9_2 and
pre-miR-125b_2 from immunoprecipitates with antibodies against FLAG (FLAG-tagged NICD) and RBPj compared with IgG negative control
(n = 3).
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Figure 5. Reciprocal Interaction between miR-9/9* and the
Notch Pathway
Proposed model for the identified interactions between miR-9/9*
and the Notch pathway according to recent findings. Dashed lines
indicate information integrated from studies in other model or-
ganisms (zebrafish: Coolen et al., 2012; mouse: Bonev et al., 2012).The NICD/RBPj Complex Interacts Physically with
Regions Upstream of the miR-9/9* Loci
In bioinformatics analyses we identified RBPj binding
sites in the genomic regions upstream of all three miR-
9/9* loci and one binding site upstream of the miR-
125b_2 locus (Figure S4B). As pri-miR-9_2 was the only
precursor strongly detectable in lt-NES cells and smNPCs
(Figures 4E and S3D), we focused on the two binding sites
predicted in the upstream region of the miR-9_2 genomic
locus. To explore whether there is a direct interaction
of the NICD/RBPj complex with these sites, we per-
formed chromatin immunoprecipitation (ChIP) assays
with antibodies against RBPj and FLAG tag using extracts
from lt-NES cells overexpressing a FLAG-tagged NICD
construct. The predicted binding sites upstream of the
miR-9_2 locus were both enriched according to semi-
quantitative PCR analyses following immunoprecipita-
tion with both anti-FLAG and anti-RBPj antibodies
compared with an immunoprecipitation with an immu-
noglobulin G (IgG) control antibody (Figure 4G). Similar
results were observed for the HES1 promoter region
(Figure 4G). In contrast, the unique RBPj binding site
upstream of the miR-125b_2 locus was not enriched
(Figure 4G). Overall these data show a recruitment of
the NICD/RBPj complex to the miR-9_2 genomic locus,214 Stem Cell Reports j Vol. 7 j 207–219 j August 9, 2016thereby strongly suggesting that Notch is a direct tran-
scriptional modulator of miR-9/9*.DISCUSSION
Notch Signaling is Important for Neural Stem Cell
Maintenance
Notch signaling is an important player in stem cell self-
renewal in general. However, the impact of Notch on neu-
ral stem cells strictly depends on the level of its activation
(Guentchev and McKay, 2006). Reduced levels of Notch
signaling commit neural stem cells to neuronal differentia-
tion (Borghese et al., 2010; Lutolf et al., 2002) and induce
severe defects in development of the CNS (reviewed in
Chiba, 2006). In turn, too much Notch activity can lead
to quiescence, e.g., in adult neural stem cells (Chapouton
et al., 2010), or in some other context may induce tumori-
genesis (Harper et al., 2003; Pierfelice et al., 2008; Radtke
and Raj, 2003; Tchorz et al., 2012). Due to these dose-
dependent effects of Notch signaling, a tight control of
its activity is crucial to ensure homeostatic stem cell self-
renewal.miR-9/9* Target Notch Signaling at Different Levels
Considering their ability to regulate more than one target
gene at once, miRNAs represent optimal candidates to fine-
tune key signaling pathways such as Notch in a stringent
manner. In addition,previous studies inanimalmodels indi-
cated a potential connection between the Notch signaling
cascade and brain-enriched miR-9/9*. In mouse, expression
of Notch1 and Hes1 was shown to change depending on
miR-9 levels (Bonev et al., 2012; Jing et al., 2011). We were
interested in whether this interaction is also operational in
human cells. Interestingly, our data show that, upon
miR-9/9* overexpression, NOTCH1 mRNA levels are not
downregulated in the human neural stem cells studied
here. On the other hand, we confirmed that also in human
neural cells HES1 is a target of miR-9, in line with what has
been described for its homologs in frog (Bonev et al.,
2011), mouse (Bonev et al., 2012), and zebrafish (Coolen
et al., 2012). Particularly in mouse, Bonev et al. (2012)
have proposed the existence of a double-negative feedback
loop betweenHes1 andmiR-9, which regulates their oscilla-
tory expression and activity during neural development.
We further identified NOTCH2 as an additional target of
miR-9/9*, which adds a second loop to the miR-9/9*-based
regulation of Notch activity in neural stem cells (Figure 5).
The phenotype induced by modulating the activity of a
single miRNA is rarely due to a single target. The effect of
a miRNA is rather the result of concomitantly fine-tuning
the expression of several targets. In this regard our study
is emblematic, showing how bifunctional miR-9/9* mildly
(2-fold downregulation) impact on multiple members of
the Notch pathway (i.e., NOTCH2 and HES1; Figure 5).
Yet the cumulative effect on these different targets turns
out to be functionally significant for neural stem cell ho-
meostasis. In addition, according to target prediction anal-
ysis, miR-9/9* might even regulate more components of
the Notch signaling cascade (Table S1) or cooperative fac-
tors, such as FoxO1, which was recently identified as a
target of miR-9 in mouse adult neural stem cells (Kim
et al., 2015). These potential additional targets could
further contribute to the effects elicited by miR-9/9*
overexpression. Together with studies in other model or-
ganisms, our work points to bifunctional miR-9/9* as an
evolutionarily conservedmodulator of the Notch signaling
pathway in the context of neural stem cell development
and maintenance. However, in addition to regulating
Notch signaling, miR-9 and miR-9* may modulate other
major pathways as was shown, e.g., for JAK-STAT (Kim
et al., 2011; Zhao et al., 2015). Thus, miR-9/9* might func-
tion as regulatory node mediating crosstalk among
different signaling cascades within the same cell.
Reciprocal Regulation of miR-9/9* Expression by
Notch Activity
Because miR-9/9* is a known pro-neurogenic factor
(Laneve et al., 2010; Packer et al., 2008; Yoo et al., 2009;
Zhao et al., 2009), its positive regulation by anti-neu-
rogenic Notch in human neural stem cells was initially un-
expected. However, this is not the first case whereby a
developmentally relevant gene was found to promote
expression of its own negative regulator as shown for
SOX2 and the miR-200 family (Peng et al., 2012). We
were interested in whether Notch directly impacts on
miR-9/9* expression in a similar fashion. As modulation
of Notch activity resulted in changes in levels of miR-9,
miR-9*, and their primary transcript pri-miR-9_2 in both
lt-NES cells and smNPCs, we searched for transcription fac-
tor binding sites in the promoter regions driving miR-9/9*
expression. In previous studies, it was reported that the
distance of Pol-II enrichment in the genomic regions near
pre-miRNAs varies between 0 and 40 kb (Corcoran et al.,
2009). For our investigation of predicted RBPj binding sites
we particularly searched within the 10-kb region upstream
of pre-miR-9/9*, as this was proposed to be the average
distance of the Pol-II peaks from pre-miR locations (Cor-
coran et al., 2009). We identified two RBPj binding sites
upstream of the miR-9_2 genomic locus (Figure S4B) and
demonstrated by ChIP assay that the NICD/RBPj complex
is recruited to these sites. Taken together, these data
strongly suggest that Notch contributes to the transcrip-
tional control of miR-9/9* in human neural stem cells,
similar to the findings recently made in zebrafish (Coolen
et al., 2012).Relevance of Fine-Tuning Effects of Notch Activity in
Development and Homeostasis
In a recent report we have shown that in lt-NES-cell overex-
pression of miR-9/9* leads to impaired self-renewal and
premature neuronal differentiation (Roese-Koerner et al.,
2013). Interestingly, similar effects were observed upon in-
hibition of the Notch signaling cascade (Borghese et al.,
2010). Antagonistic roles for miR-9/9* and Notch were
also suggested by a number of studies in model organisms.
Knockout of the miR-9_2 and miR-9_3 genomic loci leads
to a reduction in early-born neurons and increased prolifer-
ation of neural progenitors in the murine subpallium
(Shibata et al., 2011). In turn, ablation of Notch activity
in murine neuroepithelial cells leads to premature
neuronal differentiation (Lutolf et al., 2002).
So far, little is known about these regulatorymechanisms
in humans due to limited access to the developing human
nervous system. In this context, our study employs the
potential of lt-NES cells to address such questions—at a
reductionist level—in human neuroepithelial stem cells.
This robust cell-culture model opened a window enabling
us to catch a glimpse of mechanisms underlying human
neurogenesis integrating knowledge gained in model or-
ganisms. The data gathered in lt-NES cells demonstrate
the existence of a negative feedback mechanism between
bifunctional miR-9/9* and the whole Notch pathway in
human neural stem cells. To explore whether this feed-
backmechanism also applies to other neural stem cell pop-
ulations, we extended our study to a recently described
small-molecule-induced neural precursor cell population
(smNPCs; Reinhardt et al., 2013). Although both cell pop-
ulations represent multipotent neural stem cells, they
differ with respect to their growth pattern, regional iden-
tity, and differentiation propensity. Compared with lt-
NES cells, smNPCs do not form rosettes but grow as dense,
non-polarized cell clusters. In addition, smNPCs readily
give rise to both CNS and neural crest derivatives (Rein-
hardt et al., 2013). The fact that both cell populations
show the same reciprocal interaction between miR-9/9*
and Notch suggests that this regulatory loop is not a spe-
cific feature of lt-NES cells but is amore generalmechanism
calibrating the balance between self-renewal and differenti-
ation of neural stem cells.
While Notch contributes to pri-miR-9/9* transcription,
mature miR-9 and miR-9* repress, for example, NOTCH2,
HES1, and perhaps further members of the Notch pathway
(Table S1). The functional relevance of this interaction is
reflected by the fact that enhancement of neuronal differ-
entiation induced by overexpression of miR-9/9* in lt-NES
cells is abolished by overexpression of Notch2-ICD. In line
with this, the impairment of neuronal differentiation re-
sulting from inhibition of miR-9/9* activity is abolished
by inhibition of Notch signaling via DAPT treatment.Stem Cell Reports j Vol. 7 j 207–219 j August 9, 2016 215
This reciprocal regulation may help to tightly control the
delicate balance between neural stem cell self-renewal
and differentiation, thereby likely contributing to regulate
the time point when cells commit to neurogenesis. It is
tempting to speculate that it might even prevent stem cells
from crossing the border between self-renewing prolifera-
tion and tumorigenic growth.
In summary, our data generated in different human neu-
ral stem cell populations show that miR-9/9* target the
Notch downstream effector HES1 and that NOTCH2 is a
functional target of miR-9/9*. Conversely, our experi-
mental observations strongly suggest that Notch activity
regulates miR-9/9* expression via direct interaction of its
transcriptional complex with the promoter region of the
miR-9_2 genomic locus. Together, these data indicate
that the Notch signaling pathway and miR-9/9* engage
in reciprocal regulation, which directs human neural
stem cell self-renewal and differentiation (Figure 5).EXPERIMENTAL PROCEDURES
Cell Culture and Generation of Stably Transduced Cell
Lines
Human lt-NES cells (derived from I3 or H9.2 ES cell lines) were
derived as previously described (Koch et al., 2009) with somemod-
ifications as described in Supplemental Experimental Procedures.
Lt-NES cells were propagated on polyornithine/laminin-coated
dishes in proliferation medium (N2-medium containing 1:1,000
B27 supplement [Invitrogen], 10 ng/ml FGF2, and 10 ng/ml EGF
[both R&D systems]) and split every 2–3 dayswith trypsin in a ratio
of 1:2 to 1:3. Neuronal differentiation was performed on Matrigel-
coated dishes (BD Biosciences) in medium devoid of growth
factors, as previously described (Koch et al., 2009). Human iPS
cell-derived smNPCs (small-molecule neural precursor cells) were
established and propagated as described by Reinhardt et al.
(2013) (see also Supplemental Experimental Procedures).
For pharmacological inhibition of the Notch signaling pathway,
DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine
t-butyl ester, Sigma-Aldrich) was dissolved in DMSO (Sigma-Al-
drich) and used at a final concentration of 5 mM. DMSO (0.1%)
was used as vehicle control.
We genetically modified our cells to overexpress the miR-9_1
locus, human NOTCH1-ICD, NOTCH2-ICD (Capobianco et al.,
1997), DN-MAML1-GFP (Weng et al., 2003), or GFP alone as
control using doxycycline-inducible lentiviral vectors. For further
details on cloning and lentiviral transduction, please refer to Sup-
plemental Experimental Procedures.
Luciferase Assay
The dual luciferase constructs were generated by cloning an miR-9
binding site or the 30 UTR NOTCH1, NOTCH2, and HES1, respec-
tively into the multiple cloning site downstream of the Renilla
luciferase cassette in the psiCHECK2 vector (Promega). The
primers used for cloning are listed in Table S2. Cells were trans-
fected with 25 ng/ml of the suitably modified psiCHECK2 vectors216 Stem Cell Reports j Vol. 7 j 207–219 j August 9, 2016described above, using Lipofectamine 2000 (Invitrogen). After
24 hr the cells were lysed using passive lysis buffer. The lysates
were then analyzed on a microplate luminometer (Berthold) using
substrates for firefly luciferase (0.5 mM D-luciferin, PJK) and
Renilla luciferase (0.04mMcolenterazine, PJK). Changes in Renilla
luciferase activity were normalized to firefly activity.
Transfection of Synthetic miRNAMimics or Inhibitors
Lt-NES cells were seeded to reach 70% confluence at the time of
transfection. Cells were transfected with a final concentration of
5 nMmiScript miRNAmimic (Qiagen) or AllStars negative control
siRNA (Qiagen), or 50 nM miScript miRNA inhibitor (Qiagen) or
negative control inhibitor (Qiagen), using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Medium was changed 4 hr after transfection. Transfections were
performed every other day.
Real-Time qRT-PCR Analyses
Total RNA sampleswere extracted using peqGOLDTriFast (Peqlab),
DNaseI treated (Invitrogen), and quantified by Nanodrop (Thermo
Scientific) before generating cDNA by reverse transcription. Real-
time qRT-PCRs were performed on an Eppendorf Mastercycler
using the SYBR Green detectionmethod. Specifications for miRNA
andmRNAqRT-PCR analyses are described in Supplemental Exper-
imental Procedures.
Semi-quantitative PCR Analyses of Pri-miRNAs
Semi-quantitative PCR analyses were carried out on cDNA pro-
duced with an iScript Reverse Transcription Kit (Bio-Rad) using
Taq-DNA Polymerase (Invitrogen) according to themanufacturer’s
protocol. Fetal brain mRNA was purchased from Stratagene
(Agilent). Primers used are listed in Table S3.
Chromatin Immunoprecipitation
ChIP was carried out in triplicates with the Magna ChIP G Kit
(Millipore) according to the manufacturer’s protocol. The anti-
bodies used were anti-RPBj (Abcam, ab25949; 1:100) and anti-
Flag-Tag (Millipore, MAB3118; 1:100).
Subsequent semi-quantitative PCR analyses were carried out
with Taq-DNA polymerase (Invitrogen) according to the manufac-
turer’s protocol. Primers used are listed in Table S4.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (Sigma-Aldrich), permea-
bilized with 0.1% Triton X-100 (Sigma-Aldrich), blocked with 10%
fetal calf serum (FCS) (Invitrogen), and stained with primary anti-
body (bIII-tubulin, Covance, MMS-435P; 1:2,000) and secondary
antibody (Cy3-goat-anti-mouse, Jackson ImmunoResearch, 115-
165-044; 1:1,000) in 5% FCS in PBS (Invitrogen) overnight. Fixed
samples were counterstainedwith DAPI (Sigma-Aldrich). Specifica-
tions for image analysis are given in Supplemental Experimental
Procedures.
Western Blot
Protein samples were obtained from I3 lt-NES cells after 4 days of
doxycycline treatment using RIPA buffer containing Proteinase
Inhibitor cocktail (Calbiochem). 40 mg of protein extracts were
loaded onto an SDS-PAGE gel, run at 100 V for 2 hr, and blotted
onto a nitrocellulose membrane (Carl-Roth) at 70 V for 2 hr. The
membrane was blocked with 5% milk powder and incubated with
the primary antibody. Detection was carried out with a peroxidase-
conjugated secondary antibody andMillipore ECL solutions accord-
ing to the manufacturer’s protocol. Further details for the specific
antibodies are given in Supplemental Experimental Procedures.
Northern Blot
Non-radioactive northern blot was carried out with 20–40 mg of
total RNA sample as described in Stappert et al. (2013). SnRNA
U6 was used as loading control.
Statistical Analysis
All experiments were carried out in at least three independent
experiments (n). Statistical analysis was carried out using the
GraphPad Prism 6 (GraphPad Software). Results from Student’s
t test are stated as *p % 0.05, **p % 0.01, and ***p % 0.001. The
number of independent replicates (n) as well as statistical analyses
for each experiment is stated in the figure legends.
Target Prediction
miRNA target prediction was performed with the MiRWalk data-
base, which is available online (Dweep et al., 2011). Five prediction
algorithms (miRanda, miRDB, miRWALK, RNA22, and Targetscan)
were chosen for comparison. Table S1 lists the number of algo-
rithms predicting binding of the miRNA analyzed to the target
mRNA.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimen-
tal Procedures, four figures and four tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2016.06.008.
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